Brainstorm Cell Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $94k | 467k | 0.20 |
| 2023-06-30 | $1.0M | 486k | 2.06 |
| 2023-03-31 | $1.6M | 474k | 3.30 |
| 2022-12-31 | $774k | 472k | 1.64 |
| 2022-06-30 | $1.3M | 474k | 2.75 |
| 2021-06-30 | $1.9M | 474k | 3.93 |
| 2021-03-31 | $7.4M | 2.0M | 3.80 |
| 2020-12-31 | $8.8M | 1.9M | 4.56 |
| 2020-09-30 | $32M | 1.9M | 16.92 |
| 2020-03-31 | $1.8M | 384k | 4.73 |
| 2019-12-31 | $728k | 166k | 4.40 |
| 2019-09-30 | $523k | 135k | 3.89 |
| 2019-06-30 | $507k | 130k | 3.89 |
| 2019-03-31 | $398k | 90k | 4.42 |
| 2018-12-31 | $313k | 85k | 3.67 |
| 2018-09-30 | $312k | 85k | 3.67 |
| 2018-06-30 | $329k | 83k | 3.98 |
| 2018-03-31 | $245k | 79k | 3.09 |
| 2017-09-30 | $325k | 79k | 4.11 |